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As breast cancer treatment has progressed to oﬀering
breast preservation to the majority of patients, a new
challenge has arisen. That challenge is adequate
margins on the partial mastectomy specimen. The
literature reports positive margins in 20–70% of pa-
tients, resulting in additional surgery. While the
consequences of that additional surgery probably do
not affect survival from breast cancer, they do
potentially have an affect on cosmesis, wound infec-
tion risk, and the confidence that the patient has with
the surgeon wondering ‘‘why didn’t you get it all?’’
The article ‘‘Predictors of Re-excision Among
Women Undergoing Breast Conserving Surgery for
Cancer’’ by Waljee et al.
1 attempts to identify the
factors that increase the risk of a positive margin.
This avenue of research is important in clinical
management of breast cancer, allowing surgeons to
more intelligently counsel patients regarding risk of
re-excision. The authors identiﬁed several factors that
predict a higher rate of positive margins. Smaller
breast size, surgical biopsy for diagnosis, use of
adjuvant chemotherapy, and lobular histology all
predicted a higher rate of positive margins. Another
study published in the Annals of Surgical Oncology
studied the same topic and agreed that method of
biopsy and lobular histology result in higher positive
margin rates.
2 A large prospective study reported
from the University of Louisville Breast Cancer
Sentinel Lymph Node Study included 2658 patients
treated with lumpectomy and evaluated factors that
resulted in positive margins. They found that larger
tumor size and lobular histology both resulted in
higher positive margin rates, but that method of
biopsy had no impact.
3 While these studies agree on
many risk factors for positive margins, unfortunately,
these factors, with the exception of biopsy method,
cannot be modiﬁed.
Few women would agree to undergo mastectomy
instead of lumpectomy because of a prediction of
positive margins. Because the factors predicting
higher re-excision rates are not modiﬁable, this line of
research can only result in providing additional
knowledge but cannot result in changes in practice.
Eﬀorts to investigate mechanisms that reduce the rate
of positive margins have much greater potential to
impact treatment. A number of studies have investi-
gated surgical interventions that may reduce the rate
of positive margins. Many have investigated intra-
operative pathologic assessment as a mechanism to
identify positive margins at the time of surgery so
that re-excision can be accomplished in the same
setting. These have focused primarily on touch im-
print cytology, frozen section, and gross examination.
Muttalib et al. evaluated intraoperative imprint and
scrape cytology to assess margins. While the authors
recommend adoption of the technique, the positive
margin rate reported in the study remained at 22%
with use of the technique.
4 Intraoperative assessment
of gross margins has been reported to result in a ﬁnal
margin positive rate of 25%.
5 Investigators at MD
Anderson Cancer Center evaluated a combination of
intraoperative gross margin assessment, specimen
radiography, and in some cases frozen section with a
ﬁnal positive margin rate of 20% using these meth-
ods.
6 Others have evaluated intraoperative methods
of tumor localization and their impact on positive
margins. Tafra et al. completed a randomized study
comparing cryoassisted localization with wire locali-
zation and demonstrated no difference in positive
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7 Radioguided occult lesion localization was
compared with wire localization by Nadeem et al.,
who demonstrated a positive margin rate of 83% and
57%, respectively.
8 Other techniques have focused on
volume of excision with oncoplastic techniques
allowing for larger margin excisions while maintain-
ing the cosmetic appearance of the breast. While
these techniques in intraoperative assessment and
changes in surgical technique may reduce the rate of
positive margins, they have not solved the problem.
Other possible mechanisms that are currently un-
proven but that may result in lower re-excision rates
include improved preoperative imaging to better
establish extent of disease and increased use of neo-
adjuvant chemotherapy. Studies evaluating the utility
of magnetic resonance imaging (MRI) ﬁnd an in-
creased sensitivity for detection of multicentric and
multifocal disease. Identifying this situation preop-
eratively will result in better patient selection for at-
tempted partial mastectomy. We have also found
MRI helpful in deﬁning the extent of disease in the
breast more accurately identifying the extent of
resection required. Improved neoadjuvant chemo-
therapy regimens have resulted in patients with sig-
niﬁcantly smaller tumors and in some cases patients
with a pathologic complete response. Neoadjuvant
chemotherapy regimens that include Herceptin report
a pathologic complete response rate of up to 60%.
9
Of course this would reduce those patients with po-
sitive margins by reducing the number of patients
with evidence of disease in the breast and also by
reducing the tumor volume. In fact, the study by
Waljee reported a lower positive margin rate with
neoadjuvant chemotherapy.
1
While many of these techniques may reduce the
rate of positive margins, the best reports result in at
least 20% of the patients returning to the operating
room for re-excision. This rate remains too high de-
spite our best eﬀorts. New innovative surgical tech-
niques, methods of intraoperative margin assessment,
imaging for patient selection, and improved neoad-
juvant chemotherapies are needed to prevent one in
ﬁve patients from returning to the operating room.
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